News Dive
Home
Latest News
Sri Lanka News
Australia News
India News
UK News
USA News
Support
User Guide
Advertise
Contact Us
Express Investigations
Top Categories
Australia
India
Sri Lanka
Uncategorized
United Kingdom
USA
Express Investigations
,
India
Bureaucratic hurdles and a hefty Rs 10 lakh prepayment: India’s cancer patients face barriers to accessing top-selling medication.
April 14, 2026
Express Investigations
,
India
Priced at ₹1.5 lakh per dose, ‘miracle’ cancer medication exposed as counterfeit, with fraudulent versions reaching vulnerable patients from leading hospitals.
April 13, 2026
Express Investigations
,
India
Merck & Co addresses Keytruda packaging disclosure: ‘Healthcare providers accountable for discarded materials’
April 13, 2026